首页> 外国专利> Tumor Cell Lines NM-F9 (DSM ACC2606) AND NM-D4 (DSM ACC2605) AND APPLICATIONS THEREOF

Tumor Cell Lines NM-F9 (DSM ACC2606) AND NM-D4 (DSM ACC2605) AND APPLICATIONS THEREOF

机译:肿瘤细胞系NM-F9(DSM ACC2606)和NM-D4(DSM ACC2605)及其应用

摘要

The present invention relates to a cell line selected from the group consisting of (a) a cell line denominated NM-F9 having the DSMZ accession number DSM ACC2606; (b) a cell line denominated NM-D4 having the DSMZ accession number DSM ACC2605; and subclones of (a) or (b). Additionally, the present invention provides a lysate of the cell lines or a molecule or mixture of molecules obtained from these cell lines as well as dendritic cells loaded with said lysate, co-cultivated or fused with cells from the cell lines, or a molecule or mixture of molecules obtained from these cell lines of the present invention. Moreover compositions, preferably pharmaceutical or vaccine compositions are provided which comprise the cell lines, lysate, molecules, mixture of molecules or dendritic cells of the present invention. In another aspect the present invention relates to methods for producing the aforementioned compositions. Furthermore, methods and uses for vaccination against or treatment or prevention of cancers and/or tumourous diseases are provided.
机译:本发明涉及选自以下的细胞系:(a)命名为具有DSMZ登录号DSM ACC2606的NM-F9的细胞系; (b)命名为NM-D4的细胞系,其DSMZ登录号为DSM ACC2605; (a)或(b)的亚克隆。另外,本发明提供了从这些细胞系获得的细胞系或分子或分子混合物的裂解物,以及负载有所述裂解物的树突状细胞,其与来自细胞系的细胞共培养或融合在一起,或者分子或从本发明的这些细胞系获得的分子的混合物。此外,提供了包含本发明的细胞系,裂解物,分子,分子的混合物或树突状细胞的组合物,优选地药物或疫苗组合物。在另一方面,本发明涉及用于生产上述组合物的方法。此外,提供了针对癌症和/或肿瘤性疾病的疫苗接种或治疗或预防的方法和用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号